These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18951188)

  • 1. Detection and analysis of (O-linked beta-N-acetylglucosamine)-modified proteins.
    Zachara NE
    Methods Mol Biol; 2009; 464():227-54. PubMed ID: 18951188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting the "O-GlcNAc-ome"; detection, purification, and analysis of O-GlcNAc modified proteins.
    Zachara NE
    Methods Mol Biol; 2009; 534():251-79. PubMed ID: 19277546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and analysis of proteins modified by O-linked N-acetylglucosamine.
    Zachara NE; Hart GW; Cole RN; Gao Y
    Curr Protoc Mol Biol; 2002 Feb; Chapter 17():Unit 17.6. PubMed ID: 18265305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress.
    Zachara NE; Hart GW
    Biochim Biophys Acta; 2004 Jul; 1673(1-2):13-28. PubMed ID: 15238246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global identification of O-GlcNAc-modified proteins.
    Nandi A; Sprung R; Barma DK; Zhao Y; Kim SC; Falck JR; Zhao Y
    Anal Chem; 2006 Jan; 78(2):452-8. PubMed ID: 16408927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1.
    Ball LE; Berkaw MN; Buse MG
    Mol Cell Proteomics; 2006 Feb; 5(2):313-23. PubMed ID: 16244361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.
    Zachara NE; Cheung WD; Hart GW
    Methods Mol Biol; 2004; 284():175-94. PubMed ID: 15173616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of O-GlcNAc sites on proteins.
    Whelan SA; Hart GW
    Methods Enzymol; 2006; 415():113-33. PubMed ID: 17116471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressor HIC1 (hypermethylated in cancer 1) is O-GlcNAc glycosylated.
    Lefebvre T; Pinte S; Guérardel C; Deltour S; Martin-Soudant N; Slomianny MC; Michalski JC; Leprince D
    Eur J Biochem; 2004 Oct; 271(19):3843-54. PubMed ID: 15373830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc modification: a nutritional sensor that modulates proteasome function.
    Zachara NE; Hart GW
    Trends Cell Biol; 2004 May; 14(5):218-21. PubMed ID: 15130576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WGA-based lectin affinity gel electrophoresis: A novel method for the detection of O-GlcNAc-modified proteins.
    Kubota Y; Fujioka K; Takekawa M
    PLoS One; 2017; 12(7):e0180714. PubMed ID: 28686627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
    Whelan SA; Hart GW
    Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective detection and site-analysis of O-GlcNAc-modified glycopeptides by beta-elimination and tandem electrospray mass spectrometry.
    Greis KD; Hayes BK; Comer FI; Kirk M; Barnes S; Lowary TL; Hart GW
    Anal Biochem; 1996 Feb; 234(1):38-49. PubMed ID: 8742080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar.
    Wells L; Hart GW
    FEBS Lett; 2003 Jul; 546(1):154-8. PubMed ID: 12829252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications.
    Wells L; Vosseller K; Cole RN; Cronshaw JM; Matunis MJ; Hart GW
    Mol Cell Proteomics; 2002 Oct; 1(10):791-804. PubMed ID: 12438562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and analysis of proteins modified by O-linked N-acetylglucosamine.
    Zachara NE; Cole RN; Hart GW; Gao Y
    Curr Protoc Protein Sci; 2001 Nov; Chapter 12():Unit 12.8. PubMed ID: 18429112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation of the murine estrogen receptor-alpha.
    Cheng X; Hart GW
    J Steroid Biochem Mol Biol; 2000 Dec; 75(2-3):147-58. PubMed ID: 11226831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of O-GlcNAc modification of cellular proteins in signal transduction].
    Krześlak A
    Postepy Biochem; 2007; 53(4):389-99. PubMed ID: 19024903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics.
    Khidekel N; Ficarro SB; Clark PM; Bryan MC; Swaney DL; Rexach JE; Sun YE; Coon JJ; Peters EC; Hsieh-Wilson LC
    Nat Chem Biol; 2007 Jun; 3(6):339-48. PubMed ID: 17496889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.